GlassScriptPhysician profile
Kishore K Challa
NPI 1043377062
$14,012.10
in general payments reported to CMS, 2019-2025
34 companies · $1,977 in 2025
The $1,977 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,066 · 2020: $1,343 · 2021: $1,826 · 2022: $1,917 · 2023: $2,632 · 2024: $2,251 · 2025: $1,977.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,761 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,760.84 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,971.47 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $1,926.77 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $1,733.66 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $938.98 | 2019-2025 | Airsupra, Wainua, Farxiga |
| E.R. Squibb & Sons, L.L.C. | $918.01 | 2019-2024 | Camzyos, Eliquis |
| Pfizer INC. | $900.25 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $817.98 | 2019-2025 | Jardiance |
| Amgen INC. | $743.45 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $492.44 | 2021-2025 | Verquvo, Capvaxive |
| Novo Nordisk INC | $474.72 | 2023-2025 | Wegovy, Ozempic |
| Amarin Pharma, INC. | $439.18 | 2019-2023 | |
| Boston Scientific Corporation | $424.20 | 2019-2025 | Wolverine Coronary Cutting Balloon, General - Balloon Catheters, Avvigo Guidance System |
| Kestra Medical Technology Services, INC. | $355.65 | 2022-2025 | Assure Wcd |
| Lexicon Pharmaceuticals, INC. | $290.54 | 2023-2024 | Inpefa |
| Heartflow, INC. | $251.43 | 2024-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $176.05 | 2019-2025 | Jot Dx, Confirm Rx |
| Biohaven Pharmaceuticals, INC. | $120.32 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $102.04 | 2022-2025 | |
| Actelion Pharmaceuticals US, INC. | $98.99 | 2023 | Uptravi, Opsumit |
| Abbvie INC. | $98.18 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $94.95 | 2019-2022 | |
| Rigel Pharmaceuticals, INC. | $93.73 | 2023 | Rezlidhia, Tavalisse |
| Medtronic, INC. | $79.72 | 2021 | |
| Alnylam Pharmaceuticals INC. | $79.27 | 2021-2025 | Onpattro |
| Esperion Therapeutics, INC. | $78.72 | 2020-2023 | Nexletol |
| Biotronik INC. | $53.07 | 2019-2022 | |
| Impulse Dynamics (USA) INC. | $50.14 | 2023 | Optimizer |
| Abiomed | $49.36 | 2023 | Impella |
| Shockwave Medical, INC | $41.39 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic Vascular, INC. | $34.58 | 2020 | |
| Cvrx, INC. | $30.86 | 2021 | |
| Sanofi-Aventis U.S. LLC | $20.67 | 2019 | |
| Astellas Pharma US INC | $16.82 | 2019 | |
| Vivaquant INC, Dba Rhythm Express | $14.51 | 2024 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kishore Challa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.